I. Executive Summary Background The 5 years since the publication of the first International
Consensus Statement on Allergy and Rhinology: Rhinosinusitis (ICAR‐RS) has witnessed …

Contributing Authors Isam Alobid, MD, PhD1, Nithin D. Adappa, MD2, Henry P. Barham,
MD3, Thiago Bezerra, MD4, Nadieska Caballero, MD5, Eugene G. Chang, MD6, Gaurav …

Objective This update of a 2007 guideline from the American Academy of Otolaryngology—
Head and Neck Surgery Foundation provides evidence-based recommendations to manage …

OBJECTIVE: To update the American Academy of Pediatrics clinical practice guideline
regarding the diagnosis and management of acute bacterial sinusitis in children and …

OBJECTIVE: This guideline provides evidence-based recommendations on managing
sinusitis, defined as symptomatic inflammation of the paranasal sinuses. Sinusitis affects 1 in …

The Rhinosinusitis Initiative was developed by 5 national societies. The current guidance
document is an expansion of the 2004 publication,“Rhinosinusitis: Establishing definitions …

■ Abstract The safety and efficacy of intranasal corticosteroids (INCs) are well established
for the management of allergic rhinitis, rhinosinusitis, and nasal polyps. As seen in …

Rhinosinusitis (RS) affects approximately 1 in 7 adults in the United States, and its effect on
quality of life, productivity, and finances is substantial. During the past 10 years, several …

These parameters were developed by the Joint Task Force on Practice Parameters,
representing the American Academy of Allergy, Asthma and Immunology; the American …

Rhinosinusitis is one of the most commonly diagnosed diseases in the United States.
Analysis of the Centers for Disease Control and Preventionesponsored 2010 US National …